AMS Key Statistics, Chart & Performance
The current stock price of AMS is 2.14 USD. In the past month the price increased by 1.42%. In the past year, price decreased by -32.92%.
AMS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.62 | 101.06B | ||
| CI | THE CIGNA GROUP | 9.73 | 73.86B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 125.45 | 23.08B | ||
| LH | LABCORP HOLDINGS INC | 16.05 | 21.05B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.03 | 19.57B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.27B | ||
| DVA | DAVITA INC | 12.35 | 8.05B | ||
| HIMS | HIMS & HERS HEALTH INC | 63.54 | 7.81B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 37.01 | 6.81B | ||
| CHE | CHEMED CORP | 19.64 | 6.12B | ||
| RDNT | RADNET INC | 192.5 | 5.64B | ||
| OPCH | OPTION CARE HEALTH INC | 21.87 | 5.17B |
Related stock screener links
About AMS
Company Profile
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 81 full-time employees. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The firm provides radiation therapy services both domestically and internationally.
Company Info
AMERICAN SHARED HOSPITAL SER
601 Montgomery Street, Suite 1112
San Francisco CALIFORNIA 94111 US
CEO: Raymond C. Stachowiak
Employees: 82
Phone: 14157885300
AMERICAN SHARED HOSPITAL SER / AMS FAQ
What does AMS do?
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 81 full-time employees. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The firm provides radiation therapy services both domestically and internationally.
Can you provide the latest stock price for AMERICAN SHARED HOSPITAL SER?
The current stock price of AMS is 2.14 USD. The price increased by 1.9% in the last trading session.
Does AMERICAN SHARED HOSPITAL SER pay dividends?
AMS does not pay a dividend.
What is the ChartMill rating of AMERICAN SHARED HOSPITAL SER stock?
AMS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is AMERICAN SHARED HOSPITAL SER (AMS) stock traded?
AMS stock is listed on the NYSE Arca exchange.
Can you provide the PE ratio for AMS stock?
AMERICAN SHARED HOSPITAL SER (AMS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
How many employees does AMERICAN SHARED HOSPITAL SER have?
AMERICAN SHARED HOSPITAL SER (AMS) currently has 82 employees.
AMS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AMS. When comparing the yearly performance of all stocks, AMS is a bad performer in the overall market: 88.86% of all stocks are doing better.
AMS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AMS. AMS has a bad profitability rating. Also its financial health evaluation is rather negative.
AMS Financial Highlights
Over the last trailing twelve months AMS reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS decreased by -950% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.84% | ||
| ROE | -9.97% | ||
| Debt/Equity | 0.58 |
AMS Forecast & Estimates
5 analysts have analysed AMS and the average price target is 4.59 USD. This implies a price increase of 114.49% is expected in the next year compared to the current price of 2.14.
For the next year, analysts expect an EPS growth of 44.91% and a revenue growth 8.01% for AMS